# Metformin for Weight Loss in Schizophrenia

> **NCT01177709** · NA · TERMINATED · sponsor: **Nathan Kline Institute for Psychiatric Research** · enrollment: 12 (actual)

## Conditions studied

- Schizophrenia
- Obesity

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01177709
- **Lead sponsor:** Nathan Kline Institute for Psychiatric Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** PI moved to different institution. Decided to concentrate on different studies.
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01177709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01177709, "Metformin for Weight Loss in Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01177709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*